XTNT
Xtant Medical Holdings, Inc.
$0.4500
-2.17%
$63.1M
No data for this timeframe.
Vol
Market Cap$63.1M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (89%)
Inst. Holders5 funds
Inst. Value$2.5M
Inst. Activity1 buys / 0 sells
SEC Reports2
Exchange NYSE·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001453593·Prev Close $0.4600
Recent Activity
Apr 21, 2026
SEC
Xtant Medical reported full-year 2025 revenue of $133.9 million, a 14% year-over-year increase, and achieved profitabili
8-K — Impact 7/10
Apr 13, 2026
SEC
Xtant Medical signed an exclusive U.S. distribution agreement for Dilon's HEMOBLAST Bellows product, hiring 20 sales sta
8-K — Impact 6/10
Inst.
RENAISSANCE TECHNOLOGIES LLC — ADD
919,860 shares ($721.2K)
Inst.
UBS Group AG — DOUBLED
395 shares ($257.00)
May 13, 2026
earnings_calendar
XTNT Q1 2026 Earnings Scheduled — 2026-05-13
Price Targets
$1.23
+174.1% upside
Strong Buy
Current $0.4499
Low $1.00
Median $1.20
High $1.50
3 analysts
$1.00
$1.50
Analyst Ratings
3Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 13, 2026 | BTIG | REITERATE | Buy → Buy |
| Mar 31, 2026 | BTIG | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.02 ▼ -100.0% | $-0.02 — $-0.02 | -167% YoY | 2 |
| Next Q | $-0.01 | $-0.02 — $0.00 | -172% YoY | 2 |
| Current FY | $-0.08 ▼ -60.0% | $-0.08 — $-0.08 | -318% YoY | 1 |
| Next FY | $-0.01 ▲ +75.0% | $-0.03 — $0.02 | 94% YoY | 2 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| WELLS FARGO & COMPANY/MN | — | — |
| VANGUARD GROUP INC | $1.8M | — |
| RENAISSANCE TECHNOLOGIES LLC | $721.2K | ADD |
| MORGAN STANLEY | $882.00 | — |
| BANK OF AMERICA CORP | $336.00 | TRIM |
5 institutional holders with $2.5M total value (3,194,004 shares) as of 2025-Q4. Top holders: WELLS, VANGUARD, RENAISSANCE. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | WELLS FARGO & COMPANY/MN | — | $0.00 | 0.0% | — |
| 2 | VANGUARD GROUP INC | 2,272,591 | $1.8M | 71.2% | — |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 919,860 | $721.2K | 28.8% | ADD +28.8% |
| 4 | MORGAN STANLEY | 1,125 | $882.00 | 0.0% | — |
| 5 | BANK OF AMERICA CORP /DE/ | 428 | $336.00 | 0.0% | TRIM -27.8% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | ADD | 713,915 | 919,860 | +28.8% | $721.2K | 2025-Q4 |
| UBS Group AG | DOUBLED | 1 | 395 | +39400.0% | $257.00 | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 544 | 393 | -27.8% | $254.00 | 2025-Q3 |
| CITADEL ADVISORS LLC | NEW | — | 94,115 | — | $44.2K | 2025-Q1 |
| UBS Group AG | NEAR_EXIT | 39,048 | 1 | -100.0% | — | 2024-Q4 |
| CITADEL ADVISORS LLC | EXIT | 79,356 | 0 | -100.0% | $0.00 | 2024-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 2 mixed, 0 neutral. Avg impact: 6.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (89% buy). Based on 9 analysts: 3 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$1.23 mean target
+174.1% upside
Strong Buy (3.00)
$1.00 Low
$1.50 High
| Metric | Value |
|---|---|
| Current Price | $0.4499 |
| Target Low | $1.00 |
| Target Mean | $1.23 |
| Target Median | $1.20 |
| Target High | $1.50 |
| # Analysts | 3 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.02 | $-0.02 | $-0.02 | -167.3% | -100.0% | 0↑ 1↓ | $0.0B | -30.9% | 2 |
| Next Q 2026-09-30 |
$-0.01 | $-0.02 | $0.00 | -172.5% | +0.0% | 0↑ 1↓ | $0.0B | -17.8% | 2 |
| Current FY 2026-12-31 |
$-0.08 | $-0.08 | $-0.08 | -317.6% | -60.0% | 0↑ 1↓ | $0.1B | -23.5% | 1 |
| Next FY 2027-12-31 |
$-0.01 | $-0.03 | $0.02 | 93.8% | +75.0% | 0↑ 1↓ | $0.1B | 9.4% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.020 | |
| 7d ago | $-0.010 | -0.010 |
| 30d ago | $-0.010 | -0.010 |
| 60d ago | $0.000 | -0.020 |
| 90d ago | $0.000 | -0.020 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 13, 2026 | BTIG | REITERATE | Buy | Buy |
| Mar 31, 2026 | BTIG | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 5 | 1 | 0 | 0 | 89% | |
| May 1, 2026 | 3 | 5 | 1 | 0 | 0 | 89% | |
| Apr 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Mar 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Jan 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 13, 2026
earnings_calendar
XTNT Q1 2026 Earnings Scheduled — 2026-05-13
Apr 30, 2026
earnings_calendar
XTNT Q1 2026 Earnings Scheduled — 2026-04-30
Mar 31, 2026
earnings_calendar
XTNT Q4 2025 Earnings Before Market Open — 2026-03-31
Mar 20, 2026
earnings_calendar
XTNT Q4 2025 Earnings Before Market Open — 2026-03-20
Mar 5, 2026
earnings_calendar
XTNT Q4 2025 Earnings Before Market Open — 2026-03-05
Mar 4, 2026
earnings_calendar
XTNT Q4 2025 Earnings Before Market Open — 2026-03-04